AU2003233998A1 - Ddah modulators in the treatment of pain - Google Patents

Ddah modulators in the treatment of pain

Info

Publication number
AU2003233998A1
AU2003233998A1 AU2003233998A AU2003233998A AU2003233998A1 AU 2003233998 A1 AU2003233998 A1 AU 2003233998A1 AU 2003233998 A AU2003233998 A AU 2003233998A AU 2003233998 A AU2003233998 A AU 2003233998A AU 2003233998 A1 AU2003233998 A1 AU 2003233998A1
Authority
AU
Australia
Prior art keywords
ddah
modulators
pain
treatment
ddah modulators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003233998A
Inventor
Karl Peter Giese
Keiko Mizuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Publication of AU2003233998A1 publication Critical patent/AU2003233998A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003233998A 2002-05-16 2003-05-15 Ddah modulators in the treatment of pain Abandoned AU2003233998A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0211297.7 2002-05-16
GBGB0211297.7A GB0211297D0 (en) 2002-05-16 2002-05-16 Pain treatment
PCT/GB2003/002088 WO2003097084A1 (en) 2002-05-16 2003-05-15 Ddah modulators in the treatment of pain

Publications (1)

Publication Number Publication Date
AU2003233998A1 true AU2003233998A1 (en) 2003-12-02

Family

ID=9936850

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003233998A Abandoned AU2003233998A1 (en) 2002-05-16 2003-05-15 Ddah modulators in the treatment of pain

Country Status (3)

Country Link
AU (1) AU2003233998A1 (en)
GB (1) GB0211297D0 (en)
WO (1) WO2003097084A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100278937A1 (en) * 2005-10-06 2010-11-04 Das Gupta Tapas K Compositions and methods to prevent and/or treat cancer with pa-card
JP7066850B2 (en) * 2018-07-10 2022-05-13 オリンパス株式会社 Phototherapy support device, phototherapy system and phototherapy support method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60043533D1 (en) * 1999-01-26 2010-01-28 Univ London
US20030138803A1 (en) * 2001-07-27 2003-07-24 Brooksbank Robert Alan Identification and use of molecules implicated in pain

Also Published As

Publication number Publication date
GB0211297D0 (en) 2002-06-26
WO2003097084A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
AU2003202196A1 (en) Devices and methods for heart valve treatment
AU2003216162A1 (en) Iontophoretic treatment device
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU2003283257A1 (en) Scalp treatment
AU2003202075A1 (en) Modulator of the notch signalling pathway and use thereof in medical treatment
AU2002357830A1 (en) Methods and devices for therapeutic treatment cardiac and other pathologies
AU2003226537A1 (en) Modulators of the notch signalling pathway and uses thereof in medical treatment
AU2003227944A1 (en) Ddah modulators in the treatment of pain
GB0213869D0 (en) The treatment of pain
AU2002319286A1 (en) Skin treatment
AU2002352566A1 (en) Use of corrinoids in the treatment of skin diseases
AU2003293500A1 (en) Lactoferrin in the reduction of pain
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2003228243A1 (en) Ultrasonic device for the treatment of hair and other fibers
AU2003233998A1 (en) Ddah modulators in the treatment of pain
AU2003268939A1 (en) Bisphosphonates for the treatment of antheroscleorosis and devices comprising them
AU2003275433A1 (en) Compositions and methods for treating pain
PL372534A1 (en) The treatment of pain with ifendropil
AU2003240446A1 (en) Use of mob-5 in pain
AU2003904303A0 (en) Nerve function and tissue healing
AU2003217432A1 (en) Angiopoietin-1 in the treatment of disease
AU2003215725A1 (en) Materials and methods relating to the treatment of lymphoma
AU2003273817A1 (en) Increasing of the resorption of substances via skin and mucous membranes
AU2003293714A1 (en) Methods for the treatment of chronic pain and compositions therefor
AU2002324184A1 (en) Use of a lentiviral vector in the treatment of pain

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase